Sleep therapy may boost quit rates for tobacco and cannabis users
NCT ID NCT07202351
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether screening and treating sleep disorders during tobacco or cannabis cessation therapy helps people stay abstinent longer. 80 participants will either get usual care or extra sleep-focused care. The study follows them for 6 months to see if addressing sleep issues reduces relapse.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
screening and management of sleep disorders (cognitive behavioural therapy, image rehearsal therapy)
What this could lead to
If it works, this could point toward a simple way to improve quit rates for tobacco or cannabis by addressing sleep problems during withdrawal.
What could go wrong
This is a small pilot study with only 80 people, so results may not apply widely. The intervention adds extra steps, and sleep treatment may not directly improve abstinence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLEEP DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GHU Paris Psychiatrie et Neurosciences
RECRUITINGParis, Île-de-France Region, 75014, France
Contact